心脏术后侵袭性脓肿分枝杆菌复合群感染:流行病学、管理与临床结局
该研究回顾性分析了2013至2016年间心脏术后培养阳性为脓肿分枝杆菌复合群(MABC)的成人患者,排除心室辅助装置或心脏移植者。
要点
- 心脏术后MABC感染潜伏期较长,中位53天,需警惕迟发型感染。
- 播散性感染常见,纵隔和血液是最常见培养阳性部位。
- 尽管积极抗菌和手术清创,死亡率仍高,2年内8例死亡。
核心结论
- 心脏术后侵袭性MABC感染致高发病率和高死亡率,需新治疗策略并遵守感染预防指南。
研究设计与样本
- 回顾性收集2013至2016年心脏术后MABC培养阳性患者,排除心室辅助装置或心脏移植者,分析特征、治疗和结局。
主要发现
- 播散性感染常见,最常见培养阳性部位为纵隔(n=7)和血液(n=7)。
- 患者接受中位24周(IQR 5-33周)含多种静脉药物的联合抗菌治疗,6例因阿米卡星、利奈唑胺或替加环素不良事件需调整抗生素。
- 8例接受手术管理,6例需多次胸骨清创,8例诊断后2年内死亡,其中4例直接归因于MABC感染。
临床怎么用
- 心脏术后出现不明原因发热或纵隔/血流感染时,应考虑MABC并送培养,尤其有加热-冷却单元暴露史者。
- 治疗需联合长疗程静脉抗菌药物和积极手术清创,但需监测阿米卡星、利奈唑胺和替加环素的不良反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We recently mitigated a clonal outbreak of hospital-acquired Mycobacterium abscessus complex (MABC), which included a large cluster of adult patients who developed invasive infection after exposure to heater-cooler units during cardiac surgery. Recent studies have detailed Mycobacterium chimaera infections acquired during cardiac surgery; however, little is known about the epidemiology and clinical courses of cardiac surgery patients with invasive MABC infection. METHODS: We retrospectively collected clinical data on all patients who underwent cardiac surgery at our hospital and subsequently had positive cultures for MABC from 2013 through 2016. Patients with ventricular assist devices or heart transplants were excluded. We analyzed patient characteristics, antimicrobial therapy, surgical interventions, and clinical outcomes. RESULTS: Ten cardiac surgery patients developed invasive, extrapulmonary infection from M. abscessus subspecies abscessus in an outbreak setting. Median time from presumed inoculation in the operating room to first positive culture was 53 days (interquartile range [IQR], 38-139 days). Disseminated infection was common, and the most frequent culture-positive sites were mediastinum (n = 7) and blood (n = 7). Patients received a median of 24 weeks (IQR, 5-33 weeks) of combination antimicrobial therapy that included multiple intravenous agents. Six patients required antibiotic changes due to adverse events attributed to amikacin, linezolid, or tigecycline. Eight patients underwent surgical management, and 6 patients required multiple sternal debridements. Eight patients died within 2 years of diagnosis, including 4 deaths directly attributable to MABC infection. CONCLUSIONS: Despite aggressive medical and surgical management, invasive MABC infection after cardiac surgery caused substantial morbidity and mortality. New treatment strategies are needed, and compliance with infection prevention guidelines remains critical.
引用
- Baker AW, Maziarz EK, Lewis SS, et al. Invasive Mycobacterium abscessus Complex Infection After Cardiac Surgery: Epidemiology, Management, and Clinical Outcomes. Clin Infect Dis. 2021. PMID: 32133489. doi:10.1093/cid/ciaa215
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。